CIPLA
Back to Cashflow Statement
|
CIPLA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹-109 Cr | ₹-146 Cr | ₹129 Cr | ₹224 Cr | ₹-326 Cr |
What is the latest Net Cash Inflow / Outflow ratio of CIPLA ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2023 | ₹-109 Cr |
Mar2022 | ₹-146 Cr |
Mar2021 | ₹129 Cr |
Mar2020 | ₹224 Cr |
Mar2019 | ₹-326 Cr |
How is Net Cash Inflow / Outflow of CIPLA Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2023 | ₹-109 Cr | Negative | |
Mar2022 | ₹-146 Cr | Negative | |
Mar2021 | ₹129 Cr | -42.54 | |
Mar2020 | ₹224 Cr | Positive | |
Mar2019 | ₹-326 Cr | - |
Compare Net Cash Inflow / Outflow of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹114,614.5 Cr | 1% | -5% | 53.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹364,315.0 Cr | -0.1% | -6.3% | 53.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,233.0 Cr | 3.2% | 15.3% | 23.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,900.0 Cr | 1.1% | 2.2% | 26% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,426.0 Cr | 3.9% | -1.7% | 85.2% | Stock Analytics | |
MANKIND PHARMA | ₹93,499.3 Cr | -2.7% | 1.6% | NA | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | 1% |
-5% |
53.3% |
SENSEX | 1% |
2.2% |
23.7% |
You may also like the below Video Courses